(Leu-13C6,15N)-Ile-OH (TFA)

• UNSPSC Description:

  (Leu-13C6,15N)-Ile-OH (L-Leucyl-13C6,15N-L-isoleucine) TFA is the deuterium labeled Leu-Ile-OH. Leu-Ile-OH protects against neuronal death by inducing brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) synthesis[1].

• Target Antigen:

  Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/leu-13c6-15n-ile-oh-tfa.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C(F)(F)F)O.CC[C@H](C)[C@@H](C(O)=O)N[13C]([13C@H]([13CH2][13CH]([13CH3])[13CH3])[15NH2])=O

• Molecular Weight:

  365.30

• References & Citations:

  [1]Atsumi Nitta, et al. Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. J Neurosci Res. 2004 Oct 15;78(2):250-8.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported